Inclusion completed

Phase I Study of Single Agent MK-3475 in Patients With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, and Non-Small Cell Lung Carcinoma

Cancer type: Lung cancer

Phase: I

Principal Investigator: Fløtten Øystein

Country: NO

Keywords: Norway, Bergen

Status: Inclusion completed

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01295827